The effect of A1298c polymorphism of the MTHFR gene on anti-Müllerian hormone levels: experimental and Web-based analysis.
MTHFR A1298C polymorphism
PCR-RFLP
anti-müllerian hormone
male factor infertility
oocyte retrieved
Journal
Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
revised:
21
07
2021
received:
28
03
2021
accepted:
29
07
2021
pubmed:
10
8
2021
medline:
27
1
2022
entrez:
9
8
2021
Statut:
ppublish
Résumé
The 5,10-methylenetetrahydrofolate reductase (MTHFR) is an important enzyme of folate and methionine metabolism, which is expressed in human oocytes and preimplantation. Due to the involvement of MTHFR in female reproduction, we tend to evaluate the influence of MTHFR A1298C polymorphism on ovarian marker reserves such as serum anti-Müllerian hormone (AMH) levels in women after in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). A total of 100 women, who underwent ART treatment due to male factor infertility, were recruited into this study. MTHFR A1298C polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique, and serum AMH concentrations were measured by an ultrasensitive enzyme-linked immunosorbent assay (ELISA). Women with the CC genotype had higher AMH levels (4.15 ± 1.67 ng/ml), albeit not significant, than carriers with other genotypes after ovarian stimulation. No significant differences existed in terms of miscarriage and live birth rates among different genotype groups. The presence of the C mutant allele of the 1298 polymorphism in the MTHFR gene led to an increasing trend in serum AMH concentrations; however, the numbers of oocytes retrieved decreased in women with mutated genotypes. The influence of the MTHFR C677T polymorphism on embryo quality and pregnancy rate after ART cycles remains unclear.
Sections du résumé
BACKGROUND
BACKGROUND
The 5,10-methylenetetrahydrofolate reductase (MTHFR) is an important enzyme of folate and methionine metabolism, which is expressed in human oocytes and preimplantation. Due to the involvement of MTHFR in female reproduction, we tend to evaluate the influence of MTHFR A1298C polymorphism on ovarian marker reserves such as serum anti-Müllerian hormone (AMH) levels in women after in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).
METHODS
METHODS
A total of 100 women, who underwent ART treatment due to male factor infertility, were recruited into this study. MTHFR A1298C polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique, and serum AMH concentrations were measured by an ultrasensitive enzyme-linked immunosorbent assay (ELISA).
RESULTS
RESULTS
Women with the CC genotype had higher AMH levels (4.15 ± 1.67 ng/ml), albeit not significant, than carriers with other genotypes after ovarian stimulation. No significant differences existed in terms of miscarriage and live birth rates among different genotype groups.
CONCLUSION
CONCLUSIONS
The presence of the C mutant allele of the 1298 polymorphism in the MTHFR gene led to an increasing trend in serum AMH concentrations; however, the numbers of oocytes retrieved decreased in women with mutated genotypes. The influence of the MTHFR C677T polymorphism on embryo quality and pregnancy rate after ART cycles remains unclear.
Identifiants
pubmed: 34369004
doi: 10.1002/jcla.23948
pmc: PMC8418515
doi:
Substances chimiques
Anti-Mullerian Hormone
80497-65-0
MTHFR protein, human
EC 1.5.1.20
Methylenetetrahydrofolate Reductase (NADPH2)
EC 1.5.1.20
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e23948Informations de copyright
© 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Références
Reprod Biomed Online. 2016 May;32(5):503-12
pubmed: 26968928
Fertil Steril. 2007 Sep;88(3):632-8
pubmed: 17572411
Pharmacogenomics J. 2014 Oct;14(5):432-8
pubmed: 24637499
Hum Genet. 2016 May;135(5):555-568
pubmed: 27068821
PLoS One. 2012;7(6):e38700
pubmed: 22701696
J Assist Reprod Genet. 2016 Jan;33(1):67-73
pubmed: 26545911
Lancet. 2006 Jul 15;368(9531):200-1
pubmed: 16844483
Hum Reprod Update. 2011 Nov-Dec;17(6):813-28
pubmed: 21862569
Reprod Biomed Online. 2016 Apr;32(4):407-13
pubmed: 26874989
J Clin Lab Anal. 2021 Sep;35(9):e23948
pubmed: 34369004
Clin Lab. 2017 May 1;63(5):927-934
pubmed: 28627828
Acta Obstet Gynecol Scand. 2015 Jan;94(1):65-71
pubmed: 25283235
Gynecol Endocrinol. 1999 Dec;13(6):410-9
pubmed: 10685335
Br J Biomed Sci. 2004;61(2):84-7
pubmed: 15250671
Clin Chim Acta. 2018 Jan;476:123-129
pubmed: 29175649
Hum Reprod Update. 2007 Mar-Apr;13(2):163-74
pubmed: 17099205
J Obstet Gynaecol India. 2013 Aug;63(4):268-72
pubmed: 24431654
Hum Reprod Update. 2007 May-Jun;13(3):225-38
pubmed: 17307774
Reprod Biomed Online. 2014 Jun;28(6):733-8
pubmed: 24746944
Reprod Biomed Online. 2009 Mar;18(3):412-5
pubmed: 19298742
J Ovarian Res. 2013 Feb 06;6(1):11
pubmed: 23388048
Int J Mol Sci. 2016 Oct 20;17(10):
pubmed: 27775595
Lancet. 2006 May 6;367(9521):1513-9
pubmed: 16679164